Human genetic approaches to diseases of lymphocyte activation
- PMID: 18795237
- PMCID: PMC3415228
- DOI: 10.1007/s12026-008-8045-x
Human genetic approaches to diseases of lymphocyte activation
Abstract
Our laboratory focuses on the study of the molecular regulation of T lymphocyte homeostasis, particularly as it relates to immunological tolerance, apoptosis, and autoimmune diseases. Through intense molecular research on the regulation of lymphocyte fate, the Fas receptor and other tumor necrosis factor receptors as well as their ligands have emerged as key regulators of T lymphocyte apoptosis. We are studying genetic abnormalities of this death pathway, particularly in the context of autoimmune lymphoproliferative syndrome (ALPS) and other non-ALPS conditions affecting lymphocyte homeostasis. These studies have led to further investigations of the regulation of the NF-kappaB signaling pathway, the molecular basis for programed cell death and viral cytopathicity, mechanisms of autoimmunity, and the regulation of mature T-cell tolerance. Our investigations promise to provide insight into the molecular mechanisms behind the regulation of immune response and contribute to the development of novel diagnostic and treatment methods for autoimmune diseases.
Figures

Similar articles
-
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.Blood. 1997 Feb 15;89(4):1341-8. Blood. 1997. PMID: 9028957
-
A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.Curr Allergy Asthma Rep. 2001 Nov;1(6):534-40. doi: 10.1007/s11882-001-0062-y. Curr Allergy Asthma Rep. 2001. PMID: 11895618 Review.
-
The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis.Clin Rev Allergy Immunol. 2001 Feb;20(1):109-20. doi: 10.1385/criai:20:1:109. Clin Rev Allergy Immunol. 2001. PMID: 11269222 Review. No abstract available.
-
[Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis].Med Sci (Paris). 2006 Jun-Jul;22(6-7):645-50. doi: 10.1051/medsci/20062267645. Med Sci (Paris). 2006. PMID: 16828042 French.
-
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.Cell. 1995 Jun 16;81(6):935-46. doi: 10.1016/0092-8674(95)90013-6. Cell. 1995. PMID: 7540117
Cited by
-
A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.J Clin Immunol. 2013 Feb;33(2):479-88. doi: 10.1007/s10875-012-9811-z. Epub 2012 Oct 11. J Clin Immunol. 2013. PMID: 23054345 Free PMC article.
References
-
- Siegel RM, Muppidi JR, Sarker M, Lobito A, Jen M, Martin D, Straus SE, Lenardo MJ. SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J Cell Biol. 2004;167(4):735–44. doi: 10.1083/jcb.200406101. - DOI - PMC - PubMed
-
- Oliveira JB, Bidère N, Niemela JE, Zheng L, Sakai K, Nix CP, Danner RL, Barb J, Munson PJ, Puck JM, Dale J, Straus SE, Fleisher TA, Lenardo MJ. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104(21):8953–8. doi: 10.1073/pnas.0702975104. - DOI - PMC - PubMed
-
- Bi LL, Pan G, Atkinson TP, Zheng L, Dale JK, Makris C, Reddy V, McDonald JM, Siegel RM, Puck JM, Lenardo MJ, Straus SE. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. BMC Med Genet. 2007;8:41. doi: 10.1186/1471-2350-8-41. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous